Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
AI Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
AI Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Asahi Kasei
Pharma
Roche, Asahi Kasei, Verastem—Fierce Pharma Asia
Roche inked a $1.2 billion obesity deal with China's Rona. Asahi Kasei won a first-in-class FDA nod. Verastem's KRAS drug showed strong early data.
Angus Liu
Oct 16, 2026 7:57am
Asahi Kasei makes good on AiCurus buyout with new FDA nod
Oct 12, 2026 10:28am
Asahi Kasei wraps years of global dealmaking into a single brand
Oct 1, 2026 7:16am
China deal growth, Daiichi CMO, Astellas-Vir—Fierce Pharma Asia
Feb 27, 2026 9:50am
Asahi Kasei's CDMO Bionova branches out into plasmid DNA
Jun 3, 2024 11:36am
Takeda, Daiichi Sankyo, Asahi Kasei—Fierce Pharma Asia
May 31, 2024 10:48am
